Active Pharmaceutical Ingredients
Commercial Anti-TB APIs and a development pipeline built for dependable global supply.
Commercial APIs & Developmental Pipeline
Our comprehensive portfolio of Active Pharmaceutical Ingredients is purpose-built to support global tuberculosis eradication. We manufacture Ethambutol HCL and Clofazimine commercially, with several next-generation molecules under development and scale-up.
| Product Name | Capacity | CAS Number | Therapeutic Category | Status |
|---|---|---|---|---|
| Ethambutol HCL | 180 MT | 1070-11-7 | Anti-Tuberculosis | Commercial |
| Clofazimine | 12 MT | 2030-63-9 | Anti-TB / Anti-Leprosy | Commercial |
| Bedaquiline | 24 MT | 843663-66-1 | Anti-Tuberculosis | Under Scale-up |
| Rifampicin | 24 MT | 13292-46-1 | Anti-Tuberculosis | Under Validation |
| Delamanid | 12 MT | 681492-22-8 | Anti-Tuberculosis | Under Validation |
| Rifapentine | 24 MT | 61379-65-5 | Anti-Tuberculosis | Under Validation |
| Rifabutin | 24 MT | 72559-06-9 | Anti-Tuberculosis | In Development |
| Pretomanid | 12 MT | 187235-37-6 | Anti-Tuberculosis | In Development |
* Standard and custom package sizes are available. DMF documentation support provided upon request.
Request API Technical Packages